1. Introduction {#sec1}
===============

In 2017, the global adult mortality rate has declined slowly; not only that, but in some cases, the mortality rate is still rising \[[@B1]\]. Noncommunicable diseases accounted for 73% of the total number of deaths worldwide, more than half of which were attributed to only four risk factors, and hypertension was one of them \[[@B2]\]. The relationship between blood pressure (BP) level and mortality (all-cause or cardiovascular disease (CVD)) has been investigated in numerous studies \[[@B3]--[@B7]\]. It is well known that BP is an ever-changing variable in individuals during follow-up \[[@B8]\]. Therefore, office BP at a single point in time did not accurately predict all-cause mortality and researchers have begun to pay attention to the relationship between BP changes and death risk in recent years. For example, Fan JH et al. \[[@B9]\] found that, relative to stable BP of normotension, having a rise in BP from normotension or prehypertension to hypertension both conferred an increased risk of total and CVD and stroke mortality. Susanne M et al. \[[@B10]\] identified 4 BP trajectories and found that ten-year BP trajectories were the strongest predictors, among different BP measures, of CVD and all-cause mortality. In Kim MK\'s study \[[@B11]\], they found that the risk of cardiovascular outcomes was increased with greater variability in systolic blood pressure (SBP) and greater BP variability leads to greater cardiac and vascular damage \[[@B12]\]. However, these studies focus on the impact of BP on outcomes at the same period, without considering both short- and long-term BP changes in one study. Short- and long-term BP changes may have different effects on mortality and it is unclear whether short- and long-term changes in BP categories are differentially associated with mortality risk.

In our study, we focused more on the changes in BP, a particularly compelling and underreported putative all-cause mortality risk factor, and to evaluate the relationship between changes in BP categories and all-cause and CVD mortality in a representative natural population.

2. Methods {#sec2}
==========

2.1. Study Population and Study Design {#sec2.1}
--------------------------------------

This is a large-scale epidemiological follow-up study. From 2004 to 2006, a multistage, random cluster sampling design was performed to select a representative sample of the rural population aged 35 years and older from Fuxin County of Liaoning Province. The detailed methodology was described elsewhere \[[@B13]\]. From January to July 2008 (follow-up 1), from July to December 2010 (follow-up 2), and from March to December 2017 (follow-up 3), investigators were invited to participate in the follow-up study. Of the 45,925 participants at baseline, 3,883 subjects missed contact information or refused to attend the follow-up, and 42,042 participants were eligible to attend the follow-up. Of these, 846 participants who were missing SBP, diastolic blood pressure (DBP), or other key variables (demographics, lifestyle, CVD disease history, and history of disease associated with stroke) at baseline were excluded. For short-term changes analyses, subjects with missing SBP, DBP, and other key variables and missing body mass index (BMI), current smoking, and current drinking at the follow-up 1 (n=10,219) and missing SBP and DBP at the follow-up 2 (n=6776) and who died before the follow-up 2 (n=197) were excluded, leaving 24,004 participants for analysis. For long-term changes, subjects with missing SBP, DBP, and other key variables at the follow-up 2 (n=10,402) and who died before the follow-up 2 (n=288) were excluded leaving 30,506 participants for analyses ([Figure 1](#fig1){ref-type="fig"}). The procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation of China Medical University, and written informed consent of all subjects or their agents was obtained.

We aim to compare the association between short- and long-term BP changes and all-cause and CVD mortality ([Figure 2](#fig2){ref-type="fig"}). Long-term BP changes were between baseline and follow-up 2, and short-term BP changes were between follow-up 1 and follow-up 2. Data on events were all collected from 2010 to follow-up 2.

2.2. Baseline Measurement {#sec2.2}
-------------------------

Data on demographic variables (age, sex, and race), current drinking \[[@B14]\], current smoking, physical activity, history of disease (stroke, coronary heart disease (CHD), family history of hypertension, diabetes, and hyperlipemia), and information on antihypertensive medications were obtained by interview with a standard epidemiological questionnaire.

Details of the BP measurements have been described elsewhere \[[@B13]\]. In this study, based on the Seven Joint National Committee (JNC7) \[[@B15]\], we divided BP into normotension, prehypertension, and hypertension (SBP / DBP\<120 / \<80 mmHg, 120-129/80-89, ≥ 140 / 90 mmHg or receiving antihypertensive medications). Next, we classified the participants according to changes in BP: group 1, maintained at normotension; group 2, from normotension to prehypertension; group 3, from normotension to hypertension; group 4, from prehypertension to normotension; group 5, maintained at prehypertension; group 6, from prehypertension to hypertension; group 7, from hypertension to normotension; group 8, from hypertension to prehypertension; group 9, maintained at hypertension; the population was divided into 9 groups.

2.3. Follow-Up {#sec2.3}
--------------

All subjects were invited to attend the follow-up. A total of 42,242 patients finished at least one time follow-up (follow-up rate 91.5%). At each visit, we collected the information on clinical end points and concurrent medication use. During each visit, three BP measurements were taken according to a standard protocol identical to that of the baseline examination. The mean value of three BP measurements was used for each participant. We then evaluated the risk of study outcomes according to BP.

2.4. Study Outcomes {#sec2.4}
-------------------

Our results included all-cause and CVD mortality. Deaths were confirmed through hospital records and direct contact with their families. We confirmed that death from CVD on the basis of autopsy reports, death certificates, medical record abstract, or information obtained from family members \[[@B16]\]. All materials were independently reviewed by the end-point assessment committee which included the certified neurologists, cardiologists, and others.

2.5. Statistical Analysis {#sec2.5}
-------------------------

Continuous variables were reported as means and standard deviations (SD), and categorical variables were expressed as frequency and percentage. The rates of events were presented as the number of events per 1000 person-years. We used multivariable Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the associations between BP categories and mortality. We calculated the risk of events for participants with altered BP levels, with reference to those with unchanged BP categories. Next, we calculated the events risk of participants with changes in BP levels and made normotension BP as a reference.

We adjusted for sex, age, race, BMI, SBP, DBP, current smoking, current drinking, education level, physical activity, antihypertensive treatment, family history of hypertension, and history of diabetes, hyperlipidemia, and CVD. Beyond that, we compared the predictive power of short-term changes and long-term changes using Fisher Z test \[[@B17]\]. A 2-sided*P* value \<0.05 was deemed significant. Moreover, receiver operating characteristic (ROC) curves were constructed, and the area under the curve (AUC) was calculated to assess the cut-off value of the SBP changes in BP elevation. All analyses were performed with SPSS statistical software version 20.0 (SPSS Inc., Chicago, Illinois, USA). A*P* value less than 0.05 was accepted as indicating statistical significance.

3. Results {#sec3}
==========

There were 24,004 participants in short-term analysis and 30,506 participants in long-term analysis, of which 49.4% and 51.1% were women, and the mean age was 51.9 (SD, 10.8) years and 50.2 (SD, 11.0) years, respectively. [Table 1](#tab1){ref-type="table"} presents the baseline characteristics of participants with short- and long-term changes in BP. For short-term, the mean (SD) of SBP and that of DBP were 131.1 (14.7) mmHg and 81.4 (10.0) mmHg, respectively. 12.7% were normotension, 54.7% were prehypertensive, and 32.6% were hypertensive. Of the long-term changes subjects, the mean BP was 133.5 (22.1)/82.3 (12.5) mmHg. The three BP categories accounted for 18.1%, 45.6%, and 36.3%, respectively.

[Figure 3](#fig3){ref-type="fig"} shows the number of cases of all-cause mortality ([Figure 3(a)](#fig3){ref-type="fig"}) and CVD mortality ([Figure 3(b)](#fig3){ref-type="fig"}) per 1000 person-years by BP categories change. In the short-term BP changes study, 1496 deaths (including 805 from CVD deaths) were identified, and the overall incidence of all-cause mortality was 6.97 per 1000 person-years (CVD mortality was 3.75 per 1000 person-years). For the long-term BP changes analysis, there were 2138 all-cause mortality (1222 CVD mortality), and the total incidences of all-cause mortality and CVD mortality were 7.83/1000 person-years and 4.47/1000 person-years, respectively.

[Table 2](#tab2){ref-type="table"} shows HRs (95%CI) for the associations between BP changes and risk of all-cause and CVD mortality. In the multivariate adjusted Cox model for all-cause mortality, compared with BP maintainers, in short-term BP analysis, we found a significant decreasing risk of BP from hypertension to prehypertension, and the HRs (95%CI) were 0.766 (0.638-0.899) for all-cause mortality and 0.729 (0.585-0.908) for CVD mortality, respectively. And the results of women were the same; the HRs (95%CIs) were 0.606 (0.448-0.822) for all-cause mortality and 0.610 (0.418-0.889) for CVD mortality, respectively. In contrast, there were significant increasing risks of BP categories changes, and participants with BP from normotension or prehypertension to hypertension had HRs (95% CI) of 1.948 (1.118-3.392) and 1.439 (1.218-1.700) for all-cause mortality. Among men, the HRs (95% CIs) were 2.374 (1.059-5.323) and 1.672 (1.366-2.047) for all-cause mortality. The difference was a significant increasing risk of BP from prehypertension to hypertension in men, and the HR (95%CIs) was 1.401 (1.041-1.884). In long-term changes, the HRs (95% CI) of participants from normotension or prehypertension to hypertension were 1.738 (1.099-2.749) and 1.203 (1.023-1.414) for all-cause mortality, and they were 2.001 (1.041-3.838) and 1.241 (1.023-1.505) for all-cause mortality in men. BP from normotension to prehypertension had HR (95% CIs) of 2.351 (1.049-5.269) for CVD mortality. And from prehypertension to hypertension HRs (95% CIs) were 1.323 (1.047-1.672) in total and 1.354 (1.019-1.798) in men for CVD mortality. The results of nondiabetics are shown in Supplementary [Appendix 1](#supplementary-material-1){ref-type="supplementary-material"}.

We also compared the effects of short- and long-term BP changes, measured as regression coefficients (*β*), and they were significantly greater in short-term changes than in long-term for all-cause mortality (total: *β*=0.667 VS *β*=0.553,*P*=0.0033; men: *β*=0.865 VS *β*=0.694,*P*\<0.001) for participants from normotension to hypertension. The same result also occurs in the prehypertension to hypertension (total: *β*=0.364 VS *β*=0.185,*P*\<0.001; men: *β*=0.514 VS *β*=0.216,*P*\<0.001). Similarly, from hypertension to prehypertension, the results were reversed (total: *β*=-0.267 VS *β*=-0.112,*P*\<0.001; women: *β*=-0.500 VS *β*=-0.104,*P*\<0.001). When analyzing CVD mortality, we also found that short-term and long-term changes are different, from normotension to prehypertension (total: *β*=-0.237 VS *β*=0.855,*P*\<0.001), prehypertension to hypertension (total: *β*=0.204 VS *β*=0.280,*P*=0.0012), and hypertension to prehypertension (total: *β*=-0.316 VS *β*=-0.103,*P*\<0.001; women: *β*=-0.494 VS *β*=-0.126,*P*\<0.001).

In [Table 3](#tab3){ref-type="table"}, we compared all the other 8 groups with the group 1 as reference. In short-term changes, from normotension to hypertension increased significantly for all-cause mortality, the HRs (95% CI) were 1.846 (1.092-3.181). In long-term changes, there were more interesting results. For participants from normotension to hypertension the HRs (95% CIs) of all-cause mortality were 1.759 (1.129-2.742) in total and 1.892 (1.005-2.737) in men, respectively. For participants from hypertension to normotension, the HRs (95% CIs) of all-cause mortality were 1.725 (1.073-2.772). There were significant increased risks of BP categories changes normotension to prehypertension (HRs 2.409; 95%CI:1.090-5.328) and prehypertension to hypertension (HRs 2.441; 95%CI:1.136-5.244) for CVD mortality. For participants from hypertension to normotension or to prehypertension or that maintain hypertension, the HRs (95% CIs) of CVD mortality were 2.924 (1.276-6.700), 2.345 (1.083-5.081), and 2.591 (1.197-5.609), respectively. There was also a significant increased risk of BP from hypertension to normotension (HR: 3.330; 95%CIs: 1.107-10.023) for CVD mortality in women. The results of nondiabetics are shown in Supplementary [Appendix 2](#supplementary-material-1){ref-type="supplementary-material"}.

For participants with elevated SBP, the cut-off value of SBP changes was evaluated by using the ROC curve to predict mortality ([Figure 4](#fig4){ref-type="fig"}). In short-term analysis ([Figure 4(a)](#fig4){ref-type="fig"}), the optimal cut-off value of SBP changes for the diagnosis of all-cause mortality was 11.5 mmHg in total, and the AUC (95% CIs) was 0.538 (0.517-0.559). And the cut-off value was 13.5 mmHg for CVD mortality; the AUC (95% CIs) was 0.543 (0.513-0.573). Among men, the cut-off values of all-cause and CVD mortality were 18.5 mmHg and 13.5 mmHg, and the AUC (95% CIs) were 0.543 (0.516-0.570) and 0.548 (0.510-0.586). Among women, for all-cause mortality, the cut-off value was 11.5 mmHg, and the AUC (95% CIs) was 0.548 (0.512-0.583). For CVD mortality, the cut-off value was 12.5 mmHg, and the AUC (95% CIs) was 0.549 (0.500-0.598). In long-term analysis, the cut-off values of all-cause mortality were 18.5 mmHg (AUC: 0.529; 95% CIs: 0.509-0.548) and they were 19.5 mmHg (AUC:0.538; 95% CIs:0.511-0.564) of CVD mortality for total. Among men, the cut-off values of all-cause and CVD mortality were 19.5 mmHg (AUC:0.538; 95% CIs:0.514-0.563) and 21.5 mmHg (AUC:0.562; 95% CIs: 0.530-0.595), respectively. The results of nondiabetics are shown in Supplementary [Appendix 3](#supplementary-material-1){ref-type="supplementary-material"}.

4. Discussion {#sec4}
=============

The main findings of the present study were the positive association between short- and long-term BP changes and the risk of all-cause and CVD mortality in rural areas of China. Overall, our data showed that, compared with people who maintain the BP status, participants with elevated BP had a high risk of all-cause and CVD mortality, and participants with reduced BP had a lower risk of all-cause and CVD mortality, both in short- and long-term changes analysis. In addition, the difference between short-term and long-term changes is statistically significant.

Our study confirmed the findings for positive associations between BP changes and all-cause mortality, which was comparable with previous studies \[[@B18]--[@B21]\]. Two studies were performed on hypertensive patients and untreated hypertensive patients at the IPC Center in Paris, and changes in individual long-term BP are independent predictors of all-cause mortality in hypertensive patients \[[@B18]\]. Data from the Minnesota Business and Professional Men Study (n=261) and the Zutphen Study were shown, and the 10-year BP trajectory was the strongest predictor of cardiovascular mortality and all-cause mortality in Minnesota \[[@B19]\]. Cardiovascular health studies concluded that long-term visit-to-visit SBP variability was independently associated with a higher risk of subsequent mortality and a meta-analysis of 13 cohort studies in Japan also presented that adjusted mortality increased with increasing BP \[[@B20], [@B21]\]. These studies found that BP changes are a powerful predictor of cardiovascular events independently of mean SBP or DBP, which is more common in previous studies. And we also got the same conclusion when studying CVD and all-cause mortality. In addition, we explored the relationship between BP changes in the longitudinal pattern over time and the risk of subsequent mortality. What is more, we used BP short- and long-term changes to explore the relationship between BP and mortality, and this research was still very scarce in China.

We believe that short- and long-term changes in BP are an independent risk factor of mortality. And the impact of short- and long-term changes on outcomes is different. BP changes are indeed the result of a complex interaction between external environmental stimuli and the response of several cardiovascular control mechanisms \[[@B22]\]. There is evidence that short-term BP changes predict terminal organ damage and cardiovascular events \[[@B23]--[@B25]\]. However, the individual biologic mechanisms by which long-term BP changes may affect risk of mortality CVD or all-cause mortality are yet unclear. This impact might be due to changes in BP that cause significant changes in vasculature exposure to pressure load over a long period of time \[[@B26]\]. These would affect the potential health of vascular tissue, thereby affecting the development or severity of CVD \[[@B27], [@B28]\]. Therefore, one hypothesis is that short- and long-term changes are different for vascular pressure states. Further studies are warranted to test for this hypothesis. We detected that the same changes in BP occur, and the shorter change time seems to affect mortality more. The content of the appeal reminds us that if only one baseline BP measurement is used, the impact of hypertension on the outcome of the event will be overestimated or underestimated! Therefore, pay special attention to sudden changes in BP. Only in this way can we better help prevent cardiovascular and all-cause mortality.

Interestingly, a declining BP in hypertensive patients increases the risk of all-cause mortality, compared with maintaining normotension, especially for CVD mortality. Some studies showed that a low DBP was associated with an increased all-cause mortality risk \[[@B29], [@B30]\]. In post hoc analyses of the Systolic Hypertension in the Elderly Program (SHEP), after fully adjusting the functional status and other confounding factors, the drop in BP is still accompanied by an increase in mortality. It is also possible that lower BP in the elderly may increase the risk of adverse outcomes \[[@B31]\]. In assessing the prevalence of BP decline in the elderly and its relationship to subsequent outcomes, Satish S et al. \[[@B32]\] found that a drop in BP may be a predictor of higher mortality risk in the elderly. This result appeared more in the elderly as shown in previous studies, but the reason is unclear.

4.1. Strengths and Limitations {#sec4.1}
------------------------------

Our study had several important strengths, which include the relatively large sample size and large number of adverse events accrued, thereby increasing the statistical power of our analyses. Moreover, in this study, information about BP was derived from the mean BP of follow-up, which helped determine the relationship between BP and adverse outcomes. Finally, in addition to looking at the effect of changes in BP Categories on death, we used the ROC curve to find the cut-off value of SBP in patients with elevated BP. Our study also had several limitations. First, the BP in this study is the average of three measurements in a day, so we might not account more for the effects of individual BP fluctuations. Secondly, our research sample only included participants in rural areas of China, and we could expect different results from more people of different ethnicity. Thirdly, we did not have enough laboratory measurements, such as cholesterol, blood glucose, and inflammatory biomarkers to control these covariates. This is why we have the low frequency off diabetes in baseline characteristics. Finally, it is also worth noting that the classification of BP changes may mask some of the individual variabilities of BP in terms of time variation and may lead to attenuation.

5. Conclusions {#sec5}
==============

In our study, using the Cox proportional hazard models with short-term BP changes and long-term BP changes entered in the same model, BP changes provided more information on risk of all-cause and cardiovascular mortality than BP at a single point in time. Our research suggests that short-term BP changes have a greater effect on mortality. And individuals who are able to maintain their BP to normal BP levels have the lowest risk for CVD and all-cause mortality. The importance of hypertension management should be widely accepted in public health practice. Prevention efforts should continue to emphasize the importance of lowering BP and maintaining normotension to reduce the mortality.
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###### 

Supplementary Appendix 1 shows HRs (95%CI) for the associations between BP changes and risk of all-cause and CVD mortality in nondiabetics. In short-term BP analysis, we found a significant decreasing risk of BP from hypertension to prehypertension, and the HRs (95%CI) were 0.768 (0.646-0.912) for all-cause mortality and 0.729 (0.584-0.909) for CVD mortality, respectively. In contrast, there were significant increasing risks of BP categories changes, and participants with BP from normotension or prehypertension to hypertension had HRs (95% CI) of 1.948 (1.118-3.392) and 1.437 (1.216-1.699) for all-cause mortality. In long-term changes, the HRs (95% CI) of participants from normotension or prehypertension to hypertension were 1.740 (1.000-2.751) and 1.194 (1.015-1.405) for all-cause mortality. BP from normotension to prehypertension had HR (95% CIs) of 2.351 (1.049-5.269) for CVD mortality. And from prehypertension to hypertension, HRs (95% CIs) were 1.326 (1.048-1.677) for CVD mortality. The effects of short- and long-term BP changes, measured as regression coefficients (*β*), were significantly greater in short-term changes than in long-term for all-cause mortality (*β*=0.667 VS *β*=0.554, P\<0.001) for participants from normotension to hypertension. The same result also occurs in the prehypertension to hypertension (*β*=0.363 VS *β*=0.178, P\<0.001). Similarly, from hypertension to prehypertension, the results were reversed (*β*=-0.264 VS *β*=-0.104, P\<0.001). When analyzing CVD mortality, we also found that short-term and long-term changes are different, from normotension to prehypertension (*β*=-0.237 VS *β*=0.855, P\<0.001), prehypertension to hypertension (*β*=0.211 VS *β*=0.282, P=0.0024), and hypertension to prehypertension (*β*=-0.317 VS *β*=-0.093, P\<0.001). In Supplementary Appendix 2, in short-term changes, from normotension to hypertension increased significantly for all-cause mortality, the HRs (95% CI) were 1.848 (1.083-3.154). In long-term changes, for participants from normotension to hypertension the HRs (95% CIs) of all-cause mortality were 1.755 (1.125-2.737). For participants from hypertension to normotension, the HRs (95% CIs) of all-cause mortality were 1.646 (1.020-2.655). There were significant increased risks of BP categories changes normotension to prehypertension (HRs 2.403; 95%CI: 1.087-5.313) and prehypertension to hypertension (HRs 2.407; 95%CI: 1.120-5.173) for CVD mortality. For participants from hypertension to normotension or to prehypertension or that maintain hypertension, the HRs (95% CIs) of CVD mortality were 2.880 (1.255-6.612), 2.339 (1.079-5.070), and 2.563 (1.183-5.551), respectively. In Supplementary Appendix 3, in short-term analysis, the optimal cut-off value of SBP changes for the diagnosis of all-cause mortality was 12.5 mmHg, and the AUC (95% CIs) was 0.537 (0.515-0.558). And the cut-off value was 13.5 mmHg for CVD mortality; the AUC (95% CIs) was 0.542 (0.512-0.572). In long-term analysis, the cut-off values of all-cause mortality were 18.5 mmHg (AUC: 0.530; 95% CIs: 0.510-0.550), and they were 19.5 mmHg (AUC: 0.542; 95% CIs: 0.516-0.569) of CVD mortality.

###### 

Click here for additional data file.

![The study population inclusion and exclusion process.](BMRI2019-5274097.001){#fig1}

![Study designs used for analysis of the associations between short- and long-term changes.](BMRI2019-5274097.002){#fig2}

![The short-term and long-term incidence of deaths and its subtypes at the different variation levels. Incident (a) all-cause mortality and (b) CVD mortality, at the different variation levels. Error bars represent 95% CI. Short-term changes: from the first follow-up (2008) to the second follow-up (2010). Long-term changes: from the baseline (2004-2006) to the second follow-up (2010). Nor: normotensive (SBP\<120mmHg and DBP\<80mmHg); Pre: prehypertension (120mmHg≤SBP≤139mmHg or 80≤DBP≤89mmHg); HT: hypertension (SBP/DBP≥140/90 mmHg). SBP: systolic blood pressure; DBP: diastolic blood pressure. CI: confidence interval.](BMRI2019-5274097.003){#fig3}

![ROC curves of maximum SBP changes to predict all-cause and CVD mortality. ROC curves (a) in short-term analysis and ROC curves (b) in long-term analysis. Short-term analysis: from the first follow-up (2008) to the second follow-up (2010). Long-term analysis: from the baseline (2004-2006) to the second follow-up (2010). ROC: receiver operating characteristics; SBP: systolic blood pressure.](BMRI2019-5274097.004){#fig4}

###### 

Baseline characteristics.

  ----------------------------------------------------------------------------------------
  Characteristics                            Study population 1 \   Study Population 2 \
                                             (n=24004)              (n=30506)
  ------------------------------------------ ---------------------- ----------------------
  Female, n (%)                              11866(49.4)            15577(51.1)

  Age (year)                                 51.9(10.8)             50.2(11.0)

  Race, n (%)                                                        

  Han                                        18553(77.3)            23617(77.4)

  Mongolian                                  5126(21.4)             6487(21.3)

  Others                                     325(1.4)               402(1.3)

  BMI (kg/m^2^)                              23.6 (2.5)             23.2 (28)

  SBP (mmHg)                                 131.1(14.7)            133.5(22.1)

  DBP (mmHg)                                 81.4(10.0)             82.3 (12.5)

  Education level, n (%)                                             

  Never or Less than 5 years                 9696(40.4)             13048(42.8)

  Primary school                             12871(53.6)            15612(51.2)

  Tertiary high school or higher education   1437(6.0)              1846(6.1)

  Physical activity, n (%)                                           

  Low                                        6147(25.6)             8351(27.4)

  Moderate                                   11011(45.9)            13824(45.3)

  High                                       6846(28.5)             8331(27.3)

  Current drinking, n (%)                    7434(31.0)             9591(31.4)

  Current smoking, n (%)                     8512(35.5)             12669(41.5)

  BP categories                                                      

  Normal, n (%)                              3038(12.7)             5520(18.1)

  Prehypertension, n (%)                     13140(54.7)            13912(45.6)

  Hypertension, n (%)                        7826(32.6)             11074(36.3)

  Family history of hypertension, n (%)      2852(11.9)             3994(13.1)

  Antihypertensive treatment, n (%)          2186(9.1)              2537(8.3)

  History of diabetes, n (%)                 86(0.4)                137(0.4)

  History of hyperlipidemia, n (%)           595(2.5)               1053(3.5)

  History of CVD, n (%)                      639(2.7)               1107(3.6)
  ----------------------------------------------------------------------------------------

Values are expressed as mean (standard deviation) or number (percentage).

BMI: body mass index; BP: blood pressure; SBP: systolic blood pressure; DBP: diastolic blood pressure; BP categories according to JNC7; study population 1: participants with short-term (2008-2010) BP category changes; Study population 2: participants with long-term (2004-2006 to 2010) BP category changes.

###### 

Associations of short- and long-term BP changes with incident all-cause and CVD mortality compared with participants who maintain BP category.

  BP Category at Baseline   BP Category at Follow-up   number   Short-term changes in blood pressure   number    Long-term changes in blood pressure   P values\#                                          
  ------------------------- -------------------------- -------- -------------------------------------- --------- ------------------------------------- ------------ --------------------- ------- -------- ---------
  Total                                                                                                                                                                                                     
  All-cause mortality                                                                                                                                                                                      
  Normotension              Normotension               1113     1.000 (Ref.)                                                                           1324         1.000 (Ref.)                            
                            Prehypertension            1585     1.256(0.793-1.990)                     0.332     0.228                                 3056         1.379(0.895-2.125)    0.146   0.321     
                            Hypertension               340      1.948(1.118-3.392)                     0.019     0.667                                 1140         1.738(1.099-2.749)    0.018   0.553    0.0033
  Prehypertension           Normotension               1876     1.057(0.818-1.366)                     0.672     0.055                                 1932         0.930(0.704-1.228)    0.607   -0.073    
                            Prehypertension            8416     1.000 (Ref.)                                                                           8211         1.000 (Ref.)                            
                            Hypertension               2848     1.439(1.218-1.700)                     \<0.001   0.364                                 3769         1.203(1.023-1.414)    0.025   0.185    \<0.001
  Hypertension              Normotension               486      0.826(0.549-1.244)                     0.361     -0.191                                641          1.157(0.884-1.516)    0.288   0.146     
                            Prehypertension            3095     0.766(0.638-0.899)                     0.002     -0.267                                3819         0.894(0.782-1.021)    0.097   -0.112   \<0.001
                            Hypertension               4245     1.000 (Ref.)                                                                           6614         1.000 (Ref.)                            
  CVD mortality                                                                                                                                                                                            
  Normotension              Normotension               1113     1.000 (Ref.)                                                                           1324         1.000 (Ref.)                            
                            Prehypertension            1585     0.789(0.360-1.730)                     0.554     -0.237                                3056         2.351(1.049-5.269)    0.038   0.855    \<0.001
                            Hypertension               340      1.626(0.666-3.969)                     0.286     0.486                                 1140         1.834(0.765-4.397)    0.174   0.606     
  Prehypertension           Normotension               1876     0.946(0.643-1.391)                     0.777     -0.056                                1932         0.975(0.646-1.473)    0.906   -0.025    
                            Prehypertension            8416     1.000 (Ref.)                                                                           8211         1.000 (Ref.)                            
                            Hypertension               2848     1.227(0.963-1.563)                     0.098     0.204                                 3769         1.323(1.047-1.672)    0.019   0.280    0.0012
  Hypertension              Normotension               486      0.639(0.355-1.147)                     0.133     -0.449                                641          1.105(0.778-1.568)    0.578   0.099     
                            Prehypertension            3095     0.729(0.585-0.908)                     0.005     -0.316                                3819         0.902(0.765-1.064)    0.222   -0.103   \<0.001
                            Hypertension               4245     1.000 (Ref.)                                                                           6614         1.000 (Ref.)                           
  Men                                                                                                                                                                                                       
  All-cause mortality                                                                                                                                                                                      
  Normotension              Normotension               271      1.000 (Ref.)                                                                           320          1.000 (Ref.)                            
                            Prehypertension            578      1.428(0.732-2.784)                     0.296     0.356                                 1263         1.427(0.763-2.667)    0.265   0.355     
                            Hypertension               117      2.374(1.059-5.323)                     0.036     0.865                                 525          2.001(1.041-3.838)    0.037   0.694    \<0.001
  Prehypertension           Normotension               682      1.111(0.795-1.552)                     0.538     0.105                                 707          1.036(0.722-1.486)    0.847   0.036     
                            Prehypertension            4645     1.000 (Ref.)                                                                           4707         1.000 (Ref.)                            
                            Hypertension               1498     1.672(1.366-2.047)                     \<0.001   0.514                                 2182         1.241(1.023-1.505)    0.029   0.216    \<0.001
  Hypertension              Normotension               165      0.812(0.442-1.490)                     0.501     -0.208                                211          1.154(0.789-1.687)    0.460   0.143     
                            Prehypertension            1723     0.853(0.692-1.052)                     0.138     -0.159                                1798         0.881(0.738-1.051)    0.160   -0.127    
                            Hypertension               2459     1.000 (Ref.)                                                                           3216         1.000 (Ref.)                            
  CVD mortality                                                                                                                                                                                            
  Normotension              Normotension               271      1.000 (Ref.)                                                                           320          1.000 (Ref.)                            
                            Prehypertension            578      0.438(0.139-1.378)                     0.158     -0.825                                1263         2.927(0.888-9.643)    0.078   1.074     
                            Hypertension               117      4.738(0.508-5.946)                     0.379     0.553                                 525          3.008(0.870-10.403)   0.082   1.101     
  Prehypertension           Normotension               682      1.009(0.611-1.669)                     0.971     0.009                                 707          1.297(0.783-2.147)    0.313   0.260     
                            Prehypertension            4645     1.000 (Ref.)                                                                           4707         1.000 (Ref.)                            
                            Hypertension               1498     1.401(1.041-1.884)                     0.026     0.337                                 2182         1.354(1.019-1.798)    0.037   0.303    0.2585
  Hypertension              Normotension               165      0.354(0.113-1.113)                     0.076     -1.038                                211          0.869(0.496-1.522)    0.624   -0.140    
                            Prehypertension            1723     0.792(0.603-1.041)                     0.095     -0.233                                1798         0.907(0.726-1.131)    0.385   -0.098    
                            Hypertension               2459     1.000 (Ref.)                                                                           3216         1.000 (Ref.)                           
  Women                                                                                                                                                                                                     
  All-cause mortality                                                                                                                                                                                      
  Normotension              Normotension               842      1.000 (Ref.)                                                                           1004         1.000 (Ref.)                            
                            Prehypertension            1007     1.032(0.525-2.028)                     0.928     0.031                                 1793         1.255(0.684-2.303)    0.464   0.227     
                            Hypertension               223      1.515(0.675-3.401)                     0.314     0.416                                 615          1.289(0.656-2.531)    0.461   0.254     
  Prehypertension           Normotension               1194     1.033(0.691-1.545)                     0.873     0.033                                 1225         0.851(0.549-1.321)    0.472   -0.161    
                            Prehypertension            3771     1.000 (Ref.)                                                                           3504         1.000 (Ref.)                            
                            Hypertension               1350     1.095(0.814-1.472)                     0.550     0.090                                 1587         1.162(0.862-1.567)    0.324   0.150     
  Hypertension              Normotension               321      0.775(0.435-1.379)                     0.386     -0.255                                430          1.155(0.786-1.698)    0.464   0.144     
                            Prehypertension            1372     0.606(0.448-0.822)                     0.001     -0.500                                2021         0.901(0.743-1.105)    0.318   -0.104   \<0.001
                            Hypertension               1786     1.000 (Ref.)                                                                           3398         1.000 (Ref.)                            
  CVD mortality                                                                                                                                                                                            
  Normotension              Normotension               842      1.000 (Ref.)                                                                           1004         1.000 (Ref.)                            
                            Prehypertension            1007     1.032(0.331-3.220)                     0.956     0.032                                 1793         1.765(0.572-5.448)    0.323   0.568     
                            Hypertension               223      1.343(0.350-5.156)                     0.667     0.295                                 615          0.549(0.119-2.543)    0.444   -0.599    
  Prehypertension           Normotension               1194     0.894(0.486-1.645)                     0.719     -0.112                                1225         0.697(0.340-1.426)    0.323   -0.362    
                            Prehypertension            3771     1.000 (Ref.)                                                                           3504         1.000 (Ref.)                            
                            Hypertension               1350     0.992(0.651-1.512)                     0.970     -0.008                                1587         1.343(0.887-2.032)    0.163   0.295     
  Hypertension              Normotension               321      0.811(0.393-1.677)                     0.573     -0.209                                430          1.330(0.844-2.094)    0.219   0.285     
                            Prehypertension            1372     0.610(0.418-0.889)                     0.010     -0.494                                2021         0.882(0.686-1.133)    0.324   -0.126   \<0.001
                            Hypertension               1786     1.000 (Ref.)                                                                           3398         1.000 (Ref.)                            

Abbreviations: normotension: subjects with blood pressure (BP) \<120/80 mmHg; prehypertension: subjects with BP of 120-139/80-89 mmHg; hypertension: subjects with BP≥140/90mmHg or antihypertensive treatment. Adjusted age, gender, ethnicity, SBP, DBP, BMI, education level, physical activity, current drinking, current smoking, family history of hypertension, history of CVD diseases, history of diabetes, history of hyperlipidemia, and antihypertensive treatment.

\#comparison of *β*.

###### 

Associations of short- and long-term BP changes with incident all-cause and CVD mortality compared with participants relative to stable BP of normotension.

  BP Category Change                   Short-term changes in blood pressure   Long-term changes in blood pressure                                        
  ------------------------------------ -------------------------------------- ------------------------------------- ------- ------ --------------------- -------
  Total                                                                                                                                                   
  All-cause mortality                                                                                                                                     
  Normotension to Normotension         1113                                   1.000 (Ref.)                                  1324   1.000 (Ref.)           
  Normotension to Prehypertension      1585                                   1.179(0.759-1.832)                    0.463   3056   1.367(0.894-2.090)    0.150
  Normotension to Hypertension         340                                    1.846(1.092-3.181)                    0.023   1140   1.759(1.129-2.742)    0.012
  Prehypertension to Normotension      1876                                   0.943(0.613-1.451)                    0.790   1932   1.137(0.718-1.799)    0.592
  Prehypertension to Prehypertension   8416                                   0.861(0.588-1.262)                    0.444   8211   1.223(0.823-1.819)    0.317
  Prehypertension to Hypertension      2848                                   1.211(0.818-1.793)                    0.339   3769   1.464(0.979-2.189)    0.064
  Hypertension to Normotension         486                                    0.726(0.415-1.272)                    0.263   641    1.725(1.073-2.772)    0.022
  Hypertension to Prehypertension      3095                                   0.672(0.437-1.032)                    0.070   3819   1.323(0.873-2.007)    0.179
  Hypertension to Hypertension         4245                                   0.893(0.581-1.372)                    0.604   6614   1.488(0.982-2.255)    0.052
  CVD mortality                                                                                                                                           
  Normotension to Normotension         1113                                   1.000 (Ref.)                                  1324   1.000 (Ref.)           
  Normotension to Prehypertension      1585                                   0.755(0.359-1.590)                    0.460   3056   2.409(1.090-5.328)    0.030
  Normotension to Hypertension         340                                    1.568(0.669-3.675)                    0.301   1140   1.922(0.820-4.505)    0.127
  Prehypertension to Normotension      1876                                   0.940(0.486-1.817)                    0.855   1932   1.774(0.770-4.085)    0.179
  Prehypertension to Prehypertension   8416                                   0.988(0.553-1.764)                    0.966   8211   1.803(0.842-3.863)    0.126
  Prehypertension to Hypertension      2848                                   1.200(0.661-2.177)                    0.549   3769   2.441(1.136-5.244)    0.022
  Hypertension to Normotension         486                                    0.727(0.319-1.657)                    0.449   641    2.924(1.276-6.700)    0.010
  Hypertension to Prehypertension      3095                                   0.819(0.435-1.542)                    0.537   3819   2.345(1.083-5.081)    0.028
  Hypertension to Hypertension         4245                                   1.127(0.599-2.119)                    0.711   6614   2.591(1.197-5.609)    0.013
  Men                                                                                                                                                     
  All-cause mortality                                                                                                                                     
  Normotension to Normotension         271                                    1.000 (Ref.)                                  320    1.000 (Ref.)           
  Normotension to Prehypertension      578                                    1.179(0.629-2.208)                    0.607   1263   1.381(0.745-2.084)    0.306
  Normotension to Hypertension         117                                    1.912(0.882-4.144)                    0.101   525    1.892(1.005-2.737)    0.048
  Prehypertension to Normotension      682                                    0.909(0.490-1.686)                    0.762   707    1.238(0.639-1.802)    0.527
  Prehypertension to Prehypertension   4645                                   0.775(0.445-1.349)                    0.367   4707   1.214(0.677-1.807)    0.515
  Prehypertension to Hypertension      1498                                   1.221(0.695-2.145)                    0.488   2182   1.476(0.818-2.154)    0.197
  Hypertension to Normotension         165                                    0.617(0.271-1.406)                    0.250   211    1.745(0.874-2.655)    0.114
  Hypertension to Prehypertension      1723                                   0.675(0.370-1.233)                    0.201   1798   1.327(0.721-1.997)    0.363
  Hypertension to Hypertension         2459                                   0.822(0.450-1.505)                    0.526   3216   1.523(0.829-2.229)    0.175
  CVD mortality                                                                                                                                           
  Normotension to Normotension         271                                    1.000 (Ref.)                                  320    1.000 (Ref.)           
  Normotension to Prehypertension      578                                    0.438(0.147-1.309)                    0.139   1263   2.77(0.849-9.0360)    0.091
  Normotension to Hypertension         117                                    1.552(0.491-4.907)                    0.454   525    2.725(0.805-9.221)    0.107
  Prehypertension to Normotension      682                                    0.735(0.303-1.782)                    0.495   707    2.277(0.668-7.759)    0.188
  Prehypertension to Prehypertension   4645                                   0.704(0.322-1.538)                    0.379   4707   1.810(0.572-5.726)    0.313
  Prehypertension to Hypertension      1498                                   0.945(0.426-2.096)                    0.889   2182   2.438(0.768-7.741)    0.130
  Hypertension to Normotension         165                                    0.267(0.067-1.071)                    0.062   211    2.334(0.655-8.320)    0.191
  Hypertension to Prehypertension      1723                                   0.612(0.265-1.415)                    0.251   1798   2.388(0.743-7.676)    0.144
  Hypertension to Hypertension         2459                                   0.779(0.337-1.802)                    0.559   3216   2.634(0.821-8.455)    0.104
  Women                                                                                                                                                   
  All-cause mortality                                                                                                                                     
  Normotension to Normotension         842                                    1.000 (Ref.)                                  1004   1.000 (Ref.)           
  Normotension to Prehypertension      1007                                   1.064(0.565-2.001)                    0.848   1793   1.316(0.723-2.394)    0.368
  Normotension to Hypertension         223                                    1.633(0.773-3.453)                    0.199   615    1.514(0.789-2.908)    0.212
  Prehypertension to Normotension      1194                                   0.922(0.500-1.701)                    0.796   1225   1.008(0.528-1.924)    0.981
  Prehypertension to Prehypertension   3771                                   0.920(0.537-1.574)                    0.760   3504   1.174(0.677-2.033)    0.568
  Prehypertension to Hypertension      1350                                   1.023(0.581-1.802)                    0.937   1587   1.374(0.783-2.410)    0.268
  Hypertension to Normotension         321                                    0.749(0.342-1.641)                    0.471   430    1.604(0.829-3.103)    0.161
  Hypertension to Prehypertension      1372                                   0.535(0.280-1.020)                    0.058   2021   1.218(0.684-2.170)    0.504
  Hypertension to Hypertension         1786                                   0.864(0.457-1.632)                    0.652   3398   1.368(0.767-2.439)    0.289
  CVD mortality                                                                                                                                           
  Normotension to Normotension         842                                    1.000 (Ref.)                                  1004   1.000 (Ref.)           
  Normotension to Prehypertension      1007                                   1.083(0.383-3.064)                    0.880   1793   1.878(0.623-5.664)    0.263
  Normotension to Hypertension         223                                    1.430(0.400-5.121)                    0.582   615    0.693(0.155-3.102)    0.632
  Prehypertension to Normotension      1194                                   1.157(0.429-3.116)                    0.773   1225   1.240(0.380-4.048)    0.721
  Prehypertension to Prehypertension   3771                                   1.376(0.576-3.291)                    0.473   3504   1.775(0.636-4.954)    0.273
  Prehypertension to Hypertension      1350                                   1.363(0.549-3.385)                    0.504   1587   2.449(0.874-6.859)    0.088
  Hypertension to Normotension         321                                    1.489(0.482-4.596)                    0.489   430    3.330(1.107-10.023)   0.032
  Hypertension to Prehypertension      1372                                   0.987(0.370-2.634)                    0.979   2021   2.147(0.759-6.070)    0.150
  Hypertension to Hypertension         1786                                   1.608(0.609-4.245)                    0.338   3398   2.453(0.868-6.929)    0.090

Abbreviations: normotension: subjects with blood pressure (BP) \<120/80 mmHg; prehypertension: subjects with BP of 120-139/80-89 mmHg; hypertension: subjects with BP≥140/90mmHg or antihypertensive treatment. Adjusted age, gender, ethnicity, SBP, DBP, BMI, education level, physical activity, current drinking, current smoking, history of CVD diseases, family history of hypertension, history of diabetes, history of hyperlipidemia, and antihypertensive treatment.
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